Company / Interest Expense
Regenerative Medical Technology Group Inc. Interest Expense History
FY2018-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$2.7M
FY2021
5-year range
$2.7M / $2.7M
FY2018-FY2021
Trend
-35.2%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $570,988 to $3M over the past 2 years.
Based on SEC 10-K filings.
$3M in FY2021 with a 3-year CAGR of +72.8%.
Increased from $570,988 to $3M over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +72.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +72.8%, indicating consistent growth.
- In FY2021, interest expense decreased 35.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -19.75 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $2.7M | -35.2% |
| FY2020 | $4.2M | +636.3% |
| FY2019 | $571.0K | +8.1% |
| FY2018 | $528.4K | - |
As of FY2021 · SEC 10-K · Updated Jun 29, 2026